Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:13PM EDT. Market open.
| Previous close | 239.43 |
| Open | 237.31 |
| Bid | 229.06 x 900 |
| Ask | 229.75 x 1200 |
| Day's range | 225.96 - 235.73 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 544,008 |
| Market cap | 11.758B |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 24.76 |
| EPS (TTM) | 9.22 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 270.80 |
ZacksCharles River (CRL) to Report Q1 Earnings: Here's What to Expect
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage Globally
WILMINGTON, Mass., April 22, 2024--In addition to advancing human health and improving quality of life, we are dedicated to a responsible tomorrow.
© 2024 Yahoo. All rights reserved.